Highnoon Laboratories Limited

KASE:HINOON Stock Report

Market Cap: PK₨37.4b

Highnoon Laboratories Past Earnings Performance

Past criteria checks 3/6

Highnoon Laboratories has been growing earnings at an average annual rate of 23.1%, while the Pharmaceuticals industry saw earnings growing at 6.3% annually. Revenues have been growing at an average rate of 19.2% per year. Highnoon Laboratories's return on equity is 24.4%, and it has net margins of 12.6%.

Key information

23.1%

Earnings growth rate

23.1%

EPS growth rate

Pharmaceuticals Industry Growth20.2%
Revenue growth rate19.2%
Return on equity24.4%
Net Margin12.6%
Last Earnings Update31 Mar 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Highnoon Laboratories makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

KASE:HINOON Revenue, expenses and earnings (PKR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 2420,9532,6436,19818
31 Dec 2319,7662,4485,72015
30 Sep 2318,8512,5215,45214
30 Jun 2317,6462,5654,57511
31 Mar 2317,0152,5484,83711
31 Dec 2215,8162,4734,64911
30 Sep 2215,4532,3644,5019
30 Jun 2214,4712,0774,4079
31 Mar 2213,6401,9674,1979
31 Dec 2113,0011,8563,9859
30 Sep 2112,3781,7253,7218
30 Jun 2112,0111,6743,5588
31 Mar 2111,2491,5993,3017
31 Dec 2010,6981,4743,1226
30 Sep 2010,2871,2933,2126
30 Jun 209,6971,1933,0005
31 Mar 209,4951,0732,9335
31 Dec 199,0481,0012,7835
30 Sep 198,7199262,6424
30 Jun 198,3568752,5314
31 Mar 197,9857922,4584
31 Dec 187,5037322,3944
30 Sep 187,1036872,2734
30 Jun 186,6696442,1684
31 Mar 186,2416232,0264
31 Dec 175,9716101,8894
30 Sep 175,6435871,7564
30 Jun 175,3945621,6494
31 Mar 175,2095391,5804
31 Dec 165,0715261,5344
30 Sep 164,9355351,4893
30 Jun 164,7725171,4563
31 Mar 164,6124941,4093
31 Dec 154,4044411,3733
30 Sep 154,1673801,3794
30 Jun 154,0203381,3264
31 Mar 153,8593021,2684
31 Dec 143,6962721,1884
30 Sep 143,5442321,1392
30 Jun 143,4162121,0891
31 Mar 143,1851861,0052
31 Dec 133,0081569584
30 Sep 132,8071528627

Quality Earnings: HINOON has high quality earnings.

Growing Profit Margin: HINOON's current net profit margins (12.6%) are lower than last year (15%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: HINOON's earnings have grown significantly by 23.1% per year over the past 5 years.

Accelerating Growth: HINOON's earnings growth over the past year (3.7%) is below its 5-year average (23.1% per year).

Earnings vs Industry: HINOON earnings growth over the past year (3.7%) did not outperform the Pharmaceuticals industry 22%.


Return on Equity

High ROE: HINOON's Return on Equity (24.4%) is considered high.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.